Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

65
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
65
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

429
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
429
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

325
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
325
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

56
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
56
Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

44
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing...
44
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

54
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
54

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MIF-MAPMS: Enhancing identification of myelin autoantigenic peptides in multiple sclerosis through multimodal information fusion.

Protein science : a publication of the Protein Society·2026
Same author

NToxSEM: Enhancing prediction of neurotoxic peptides and neurotoxins using a stacked ensemble-based multimodal framework.

Protein science : a publication of the Protein Society·2026
Same author

Cell painting and thermal proteome profiling for inference of drug targets and mechanism of action.

Molecular systems biology·2026
Same author

Benign-by-design chemistry: Reinventing ligand-based drug design at the edge of AI.

Drug discovery today·2026
Same author

AI agents in drug discovery: applications and case studies.

Drug discovery today·2026
Same author

Counting cells can accurately predict small-molecule bioactivity benchmarks.

Nature communications·2026

Related Experiment Video

Updated: Mar 6, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.8K

Towards Predicting the Cytochrome P450 Modulation: From QSAR to Proteochemometric Modeling.

Watshara Shoombuatong1, Philip Prathipati2, Veda Prachayasittikul1

  • 1Center of Data Mining and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok 10700, Thailand.

Current Drug Metabolism
|March 22, 2017
PubMed
Summary

Cytochrome P450s (CYP450) are key drug metabolizing enzymes. Computational modeling, including QSAR and proteochemometrics, is vital for understanding CYP450-ligand interactions and predicting drug ADMET properties.

Keywords:
ADMETCYP450Drug metabolismQSARcytochrome P450drug designpharmacokineticsproteochemometrics

More Related Videos

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.7K
A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

70.0K

Related Experiment Videos

Last Updated: Mar 6, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.8K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.7K
A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

70.0K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Computational Chemistry

Background:

  • Cytochrome P450s (CYP450) are crucial enzymes in drug metabolism, influencing absorption, distribution, metabolism, excretion, and toxicity (ADMET).
  • CYP450 enzymes play diverse roles beyond xenobiotic metabolism, including steroid and cholesterol biosynthesis, and fatty acid metabolism.
  • While generally detoxifying, CYP450s can sometimes produce toxic metabolites from parent drug molecules.

Purpose of the Study:

  • To provide a comprehensive overview of the cytochrome P450 enzyme family.
  • To discuss the application of computational modeling in understanding CYP450-ligand interactions.
  • To highlight the utility of quantitative structure-activity relationship (QSAR) and proteochemometric modeling.

Main Methods:

  • Review of existing literature on CYP450 functions and modulators.
  • Discussion of various computational approaches for modeling CYP450-ligand interactions.
  • Focus on ligand-based, structure-based, and systems-based computational strategies.

Main Results:

  • Computational modeling aids in rationalizing CYP450 inhibition, induction, and metabolic stability.
  • Quantitative structure-activity relationship (QSAR) models are established tools for predicting CYP450 interactions.
  • Proteochemometric modeling offers a more recent and potentially powerful approach to modeling these interactions.

Conclusions:

  • Computational methods are indispensable for advancing CYP450 research and drug development.
  • QSAR and proteochemometric modeling are key techniques for predicting drug metabolism and toxicity.
  • Future trends point towards more sophisticated computational approaches for drug design and safety assessment.